← Evidence map

TrialPloS one2016

DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment.

Rosanna Villani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

67 papers cite itlatest 60 shown

2016
…
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27997563